Renhe Pharmacy Co Ltd Capital Reinvestment Ratio
Renhe Pharmacy Co Ltd capital reinvestment ratio. Renhe Pharmacy Co Ltd (000650) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥188.23 Million) in capital expenditures (CN¥13.71 Million). Check Renhe Pharmacy Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Renhe Pharmacy Co Ltd (1998–2025)
Capital reinvestment ratio of Renhe Pharmacy Co Ltd from 1998 to 2025. This chart tracks Renhe Pharmacy Co Ltd's Capital Reinvestment Ratio across 25 annual periods. Also explore 000650 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Renhe Pharmacy Co Ltd Capital Reinvestment Ratio by Year (1998–2025)
Renhe Pharmacy Co Ltd capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Renhe Pharmacy Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥851.31 Million | CN¥74.59 Million | ▼ -82.9% |
| 2024 | 0.51x | CN¥557.26 Million | CN¥285.72 Million | ▲ +37.3% |
| 2023 | 0.37x | CN¥499.47 Million | CN¥186.55 Million | ▲ +114.5% |
| 2022 | 0.17x | CN¥1.27 Billion | CN¥221.09 Million | ▼ -72.9% |
| 2021 | 0.64x | CN¥777.72 Million | CN¥499.78 Million | ▲ +156.5% |
| 2020 | 0.25x | CN¥871.13 Million | CN¥218.21 Million | ▲ +20.6% |
| 2019 | 0.21x | CN¥693.97 Million | CN¥144.10 Million | ▲ +68.6% |
| 2018 | 0.12x | CN¥569.45 Million | CN¥70.12 Million | ▲ +40.7% |
| 2017 | 0.09x | CN¥497.86 Million | CN¥43.58 Million | ▼ -23.7% |
| 2016 | 0.11x | CN¥522.08 Million | CN¥59.92 Million | ▼ -35.5% |
| 2015 | 0.18x | CN¥434.77 Million | CN¥77.41 Million | ▼ -52.7% |
| 2014 | 0.38x | CN¥365.27 Million | CN¥137.54 Million | ▼ -14.6% |
| 2013 | 0.44x | CN¥213.36 Million | CN¥94.08 Million | ▼ -66.5% |
| 2012 | 1.32x | CN¥183.97 Million | CN¥242.10 Million | ▲ +116.5% |
| 2011 | 0.61x | CN¥166.93 Million | CN¥101.47 Million | ▲ +176.7% |
| 2010 | 0.22x | CN¥130.07 Million | CN¥28.58 Million | ▼ -24.7% |
| 2009 | 0.29x | CN¥200.58 Million | CN¥58.55 Million | ▲ +50.5% |
| 2008 | 0.19x | CN¥62.14 Million | CN¥12.05 Million | ▲ +50.6% |
| 2007 | 0.13x | CN¥35.40 Million | CN¥4.56 Million | ▼ -20.6% |
| 2006 | 0.16x | CN¥235.28 Million | CN¥38.17 Million | ▼ -87.9% |
| 2004 | 1.34x | CN¥17.55 Million | CN¥23.56 Million | ▲ +421.9% |
| 2002 | 0.26x | CN¥27.99 Million | CN¥7.20 Million | ▼ -97.1% |
| 2001 | 8.85x | CN¥3.42 Million | CN¥30.24 Million | ▲ +1553.2% |
| 1999 | 0.54x | CN¥67.37 Million | CN¥36.08 Million | ▼ -40.6% |
| 1998 | 0.90x | CN¥14.48 Million | CN¥13.04 Million | — |